相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of novel human receptor activator of nuclear factor-kB isoforms generated through alternative splicing: implications in breast cancer cell survival and migration
Anastasios D. Papanastasiou et al.
BREAST CANCER RESEARCH (2012)
RANKL inhibition: a promising novel strategy for breast cancer treatment
Eva Gonzalez-Suarez
CLINICAL & TRANSLATIONAL ONCOLOGY (2011)
RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis
Eva Gonzalez-Suarez et al.
NATURE (2010)
Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer
Daniel Schramek et al.
NATURE (2010)
The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse
Rodrigo Fernandez-Valdivia et al.
DEVELOPMENTAL BIOLOGY (2009)
Both ovarian hormones estrogen and progesterone are necessary for hormonal mammary carcinogenesis in ovariectomized ACI rats
Edward W. Blank et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Nuclear factor-κB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer
Hiroshi Nakashima et al.
CANCER RESEARCH (2006)
Regulation of cancer cell migration and bone metastasis by RANKL
DH Jones et al.
NATURE (2006)
TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-κB pathway by TRAF-binding TNFRs
J Hauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Regulation of signal transduction pathways by estrogen and progesterone
DP Edwards
ANNUAL REVIEW OF PHYSIOLOGY (2005)
Breast cancer and hormone-replacement therapy in the Million Women Study
E Banks et al.
LANCET (2003)
Involvement of upstream stimulatory factors 1 and 2 in RANKL-induced transcription of tartrate-resistant acid phosphatase gene during osteoclast differentiation
Y Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Breast cancer and post-menopausal hormone therapy
P Kenemans et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Oestrogen exposure and breast cancer risk
RC Travis et al.
BREAST CANCER RESEARCH (2003)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Cooperative E-box regulation of human GLI1 by TWIST and USF
EH Villavicencio et al.
GENESIS (2002)
IKKα provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development
YX Cao et al.
CELL (2001)
Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis
L Rajkumar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-κB through utilization of the IκB kinase and activation of the mitogen-activated protein kinase p38
LV Madrid et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Menopausal hormones and breast cancer in a biracial population
PG Moorman et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2000)
Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein
S Pugazhenthi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
RK Ross et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
